Oklahoma's cannabis industry faces regulatory fatigue as lawmakers urge a pause on new rules. How might this approach affect medical marijuana businesses and patients—and what lessons can the DMV take?

An Iowa-based psychedelic church secures confidential DEA approval and state registration to import and brew ayahuasca tea, signaling new legal and cultural questions for plant medicine communities—even beyond Iowa.

Pennsylvania party leaders say winning three Senate seats would set up swift action on adult-use legalization, expungements, and equity—while the governor remains supportive.

New EEG findings highlighted by DoubleBlind suggest baseline brain rhythms can forecast how intense an ayahuasca experience may feel—useful context for DMV readers.

Pierce County, Nevada City and Portland advance measures to make personal use of natural psychedelics a low police priority—without legalizing them—signaling a local-first policy trend.

Gov. Gavin Newsom signed AB 1965 and AB 2250, tightening cannabis product testing, expanding track-and-trace to cover delivery, and requiring COAs on request.

Psychedelic Alpha has introduced The Psychedelic News Feed Podcast, creating a new way to follow psychedelics developments. Here’s why DMV readers should care.

Marijuana Moment reports over $500K in alcohol-linked donations to Ken Paxton as his office targets local decrim policies and bans hemp-derived THC products.

Psychedelic Alpha maps how people might gain access to psychedelics. We break it down in plain English and connect the dots to DMV cannabis delivery compliance.

Alabama health officials unanimously withdrew their objection to potential federal rescheduling of medical cannabis, while the state program continues despite cannabis remaining Schedule I under Alabama law.

A new Psychedelic Alpha podcast surveys D.C.’s psychedelic moment, the FDA’s evolving medical framework, and New Zealand’s MDMA prescribers—here’s why the DMV should care.

Splashy headlines about psilocybin and LSD often outpace the science. Here’s how to read studies critically—and what that means for DMV drug policy conversations.

Lawmakers are advancing therapy-only psychedelics models. Without home cultivation, advocates warn access stays gated and the Drug War’s logic lives on.

Psychedelics are surging into the mainstream, but key knowledge holders remain sidelined. Here’s what that means for DC, Maryland, and Virginia readers in 2026.

A Southern African psilocybin species—long mislabeled and newly clarified—has cultivators buzzing. Here’s what makes P. ochraceocentrata stand out, how it’s grown, and what DMV readers should watch.

Curious about mushroom tinctures? Here’s a plain‑English guide to what they are, high‑level methods, safety, and the legal picture in DC, Maryland and Virginia—plus how other states handle it.

Facing budget shortfalls, Oregon will consolidate psilocybin and medical cannabis oversight and is proposing steep fee hikes. Here’s what’s changing, why it matters, and how DMV readers should read the tea leaves.

A University of Georgia analysis of 20M+ responses finds a 7% drop in health-related absences where medical cannabis is accessible, with strongest effects in physical jobs.

Half of Kentucky’s licensed dispensaries are now open, patient registrations have surpassed 25,000, and monthly sales are rising—signaling expanding access across the state.

Psychedelic Alpha spotlights Kimon de Greef’s look at 5‑MeO‑DMT’s ascent from Sonora to pharmaceutical interest. Here’s what DMV readers should watch and why it matters.